×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OSTX – os therapies incorporated (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OSTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
08:13 am
ostx
OS Therapies Inc (NYSE: OSTX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
Medium
Report
OS Therapies Inc (NYSE: OSTX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
4/7
06:10 am
ostx
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma [Yahoo! Finance]
Low
Report
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma [Yahoo! Finance]
4/7
06:00 am
ostx
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
Medium
Report
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
4/2
08:31 am
ostx
OS Therapies Inc (NYSE: OSTX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $19.00 price target on the stock.
Medium
Report
OS Therapies Inc (NYSE: OSTX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $19.00 price target on the stock.
4/2
08:06 am
ostx
OS Therapies to Host Analyst Day at NYSE on April 7, 2025 [Yahoo! Finance]
Low
Report
OS Therapies to Host Analyst Day at NYSE on April 7, 2025 [Yahoo! Finance]
4/2
07:40 am
ostx
OS Therapies to Host Analyst Day at NYSE on April 7, 2025
High
Report
OS Therapies to Host Analyst Day at NYSE on April 7, 2025
3/31
04:40 pm
ostx
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/31
04:30 pm
ostx
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
High
Report
OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
Date
Time
Symbol
Company Name
Action
%Chg
11/15/2024
09:47 am
ostx
os therapies incorporated
MISS
Report
-12.0%
os therapies incorporated
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
06:01 am
ostx
Form 8-K OS Therapies Inc For: Mar 31
High
Report
Form 8-K OS Therapies Inc For: Mar 31
3/31
04:39 pm
ostx
Form 8-K OS Therapies Inc For: Mar 31
High
Report
Form 8-K OS Therapies Inc For: Mar 31
3/31
04:06 pm
ostx
Form 10-K OS Therapies Inc For: Dec 31
High
Report
Form 10-K OS Therapies Inc For: Dec 31
3/12
04:30 pm
ostx
Form SCHEDULE 13D/A OS Therapies Inc Filed by: Auerbach Shalom
Medium
Report
Form SCHEDULE 13D/A OS Therapies Inc Filed by: Auerbach Shalom
2/28
06:03 pm
ostx
Form 4 OS Therapies Inc For: Feb 28 Filed by: Romness Paul A.
High
Report
Form 4 OS Therapies Inc For: Feb 28 Filed by: Romness Paul A.
2/28
04:05 pm
ostx
Form DEF 14A OS Therapies Inc For: Mar 31
High
Report
Form DEF 14A OS Therapies Inc For: Mar 31
2/28
04:05 pm
ostx
Form SCHEDULE 13D/A OS Therapies Inc Filed by: Auerbach Shalom
High
Report
Form SCHEDULE 13D/A OS Therapies Inc Filed by: Auerbach Shalom
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: